Clinical Efficacy of TroVax in the Treatment of Progressive Castration-resistant Prostate Cancer
{{output}}
With approximately 240,890 new cases expected in 2011, prostate cancer remains the leading cause of non-melanoma cancer deaths in men. Immunotherapies using viral vector-based delivery systems targeting tumor-specific antigens are being studied. Viral vector-b... ...
